Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MEM-288 |
Synonyms | |
Therapy Description |
MEM-288 is an oncolytic adenovirus containing MEM40 and CD40L transgenes, which potentially inhibits tumor growth and metastasis (Cancer Res 2020;80(16 Suppl):Abstract nr 4578). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MEM-288 | MEM288|MEM 288 | MEM-288 is an oncolytic adenovirus containing MEM40 and CD40L transgenes, which potentially inhibits tumor growth and metastasis (Cancer Res 2020;80(16 Suppl):Abstract nr 4578). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05076760 | Phase I | MEM-288 | Study of MEM-288 Oncolytic Virus in Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC) | Recruiting | USA | 0 |